254 related articles for article (PubMed ID: 21955844)
1. Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study.
Popović-Bijelić A; Kowol CR; Lind ME; Luo J; Himo F; Enyedy EA; Arion VB; Gräslund A
J Inorg Biochem; 2011 Nov; 105(11):1422-31. PubMed ID: 21955844
[TBL] [Abstract][Full Text] [Related]
2. Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs.
Plamthottam S; Sun D; Van Valkenburgh J; Valenzuela J; Ruehle B; Steele D; Poddar S; Marshalik M; Hernandez S; Radu CG; Zink JI
J Biol Inorg Chem; 2019 Aug; 24(5):621-632. PubMed ID: 31250199
[TBL] [Abstract][Full Text] [Related]
3. Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.
Kowol CR; Trondl R; Heffeter P; Arion VB; Jakupec MA; Roller A; Galanski MS; Berger W; Keppler BK
J Med Chem; 2009 Aug; 52(16):5032-43. PubMed ID: 19637923
[TBL] [Abstract][Full Text] [Related]
4. Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells.
Ohui K; Stepanenko I; Besleaga I; Babak MV; Stafi R; Darvasiova D; Giester G; Pósa V; Enyedy EA; Vegh D; Rapta P; Ang WH; Popović-Bijelić A; Arion VB
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32961653
[TBL] [Abstract][Full Text] [Related]
5. Complex formation and cytotoxicity of Triapine derivatives: a comparative solution study on the effect of the chalcogen atom and NH-methylation.
Enyedy ÉA; May NV; Pape VFS; Heffeter P; Szakács G; Keppler BK; Kowol CR
Dalton Trans; 2020 Dec; 49(46):16887-16902. PubMed ID: 33185224
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic studies of semicarbazone triapine targeting human ribonucleotide reductase in vitro and in mammalian cells: tyrosyl radical quenching not involving reactive oxygen species.
Aye Y; Long MJC; Stubbe J
J Biol Chem; 2012 Oct; 287(42):35768-35778. PubMed ID: 22915594
[TBL] [Abstract][Full Text] [Related]
7. A Ferrous-Triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase.
Shao J; Zhou B; Di Bilio AJ; Zhu L; Wang T; Qi C; Shih J; Yen Y
Mol Cancer Ther; 2006 Mar; 5(3):586-92. PubMed ID: 16546972
[TBL] [Abstract][Full Text] [Related]
8. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of biotin-conjugated anticancer thiosemicarbazones and their iron(III) and copper(II) complexes.
Kallus S; Uhlik L; van Schoonhoven S; Pelivan K; Berger W; Enyedy ÉA; Hofmann T; Heffeter P; Kowol CR; Keppler BK
J Inorg Biochem; 2019 Jan; 190():85-97. PubMed ID: 30384010
[TBL] [Abstract][Full Text] [Related]
10. Coumarin-Based Triapine Derivatives and Their Copper(II) Complexes: Synthesis, Cytotoxicity and mR2 RNR Inhibition Activity.
Stepanenko I; Babak MV; Spengler G; Hammerstad M; Popovic-Bijelic A; Shova S; Büchel GE; Darvasiova D; Rapta P; Arion VB
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207929
[TBL] [Abstract][Full Text] [Related]
11. Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition.
Besleaga I; Stepanenko I; Petrasheuskaya TV; Darvasiova D; Breza M; Hammerstad M; Marć MA; Prado-Roller A; Spengler G; Popović-Bijelić A; Enyedy EA; Rapta P; Shutalev AD; Arion VB
Inorg Chem; 2021 Aug; 60(15):11297-11319. PubMed ID: 34279079
[TBL] [Abstract][Full Text] [Related]
12. Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.
Chitambar CR; Antholine WE
Antioxid Redox Signal; 2013 Mar; 18(8):956-72. PubMed ID: 22900955
[TBL] [Abstract][Full Text] [Related]
13.
Safiarian MS; Watson RA; Lieberman RL; Barry BA; Offenbacher AR
J Phys Chem Lett; 2021 Sep; 12(37):9020-9025. PubMed ID: 34516127
[TBL] [Abstract][Full Text] [Related]
14. Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes.
Ishiguro K; Lin ZP; Penketh PG; Shyam K; Zhu R; Baumann RP; Zhu YL; Sartorelli AC; Rutherford TJ; Ratner ES
Biochem Pharmacol; 2014 Oct; 91(3):312-22. PubMed ID: 25130544
[TBL] [Abstract][Full Text] [Related]
15. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence properties and cellular distribution of the investigational anticancer drug triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and its zinc(II) complex.
Kowol CR; Trondl R; Arion VB; Jakupec MA; Lichtscheidl I; Keppler BK
Dalton Trans; 2010 Jan; 39(3):704-6. PubMed ID: 20066211
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.
Li J; Zheng LM; King I; Doyle TW; Chen SH
Curr Med Chem; 2001 Feb; 8(2):121-33. PubMed ID: 11172670
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone).
Barker CA; Burgan WE; Carter DJ; Cerna D; Gius D; Hollingshead MG; Camphausen K; Tofilon PJ
Clin Cancer Res; 2006 May; 12(9):2912-8. PubMed ID: 16675588
[TBL] [Abstract][Full Text] [Related]
19. New Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action.
Ohui K; Afanasenko E; Bacher F; Ting RLX; Zafar A; Blanco-Cabra N; Torrents E; Dömötör O; May NV; Darvasiova D; Enyedy ÉA; Popović-Bijelić A; Reynisson J; Rapta P; Babak MV; Pastorin G; Arion VB
J Med Chem; 2019 Jan; 62(2):512-530. PubMed ID: 30507173
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development.
Heffeter P; Pape VFS; Enyedy ÉA; Keppler BK; Szakacs G; Kowol CR
Antioxid Redox Signal; 2019 Mar; 30(8):1062-1082. PubMed ID: 29334758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
